Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1991 Aug 15;88(16):6981–6985. doi: 10.1073/pnas.88.16.6981

Chemoselective one-step purification method for peptides synthesized by the solid-phase technique.

S Funakoshi 1, H Fukuda 1, N Fujii 1
PMCID: PMC52217  PMID: 1871113

Abstract

The specific reaction between SH and iodoacetamide groups has been explored as the basis of an affinity-type purification procedure for peptides synthesized by the solid-phase technique. For this affinity-type purification procedure, we synthesized an SH precursor reagent bearing an acid-labile S-protecting group, pMB-SCH2CONHCH2CH2-SO2CH2CH2OCO2pNP (compound I), in which pMB is p-methoxybenzyl and pNP is p-nitrophenyl. Using this reagent, the procedure involves the following sequence of four reactions: (i) attachment of the SH function of compound I to the alpha-amino group of a peptide-resin through a base-labile sulfonylethoxycarbonyl linkage in the final step of solid-phase peptide synthesis, (ii) acid treatment to remove the S-pMB and side-chain-protecting groups employed and cleave the modified peptide from the resin, (iii) immobilization of the derived SH-peptide on an iodoacetamide-resin column, and (iv) base (5% NH4OH) treatment to release the desired peptide from the resin in nearly pure form. To facilitate this purification procedure, unreacted amino groups were acetylated in each step during solid-phase synthesis. The usefulness of this method was demonstrated by the purification of several peptides (18 to approximately 44 amino acids in length) synthesized by the 9-fluorenylmethoxycarbonyl (Fmoc)-based solid-phase technique. The principle of this affinity-type purification procedure may also be applied to the tert-butoxycarbonyl (Boc)-based solid-phase technique.

Full text

PDF
6981

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bayer E. A., Wilchek M. Application of avidin-biotin technology to affinity-based separations. J Chromatogr. 1990 Jun 27;510:3–11. doi: 10.1016/s0021-9673(01)93733-1. [DOI] [PubMed] [Google Scholar]
  2. Fujii N., Otaka A., Sugiyama N., Hatano M., Yajima H. Studies on peptides. CLV. Evaluation of trimethylsilyl bromide as a hard-acid deprotecting reagent in peptide synthesis. Chem Pharm Bull (Tokyo) 1987 Sep;35(9):3880–3883. doi: 10.1248/cpb.35.3880. [DOI] [PubMed] [Google Scholar]
  3. Guillemin R., Brazeau P., Böhlen P., Esch F., Ling N., Wehrenberg W. B. Growth hormone-releasing factor from a human pancreatic tumor that caused acromegaly. Science. 1982 Nov 5;218(4572):585–587. doi: 10.1126/science.6812220. [DOI] [PubMed] [Google Scholar]
  4. Kaiser E., Colescott R. L., Bossinger C. D., Cook P. I. Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides. Anal Biochem. 1970 Apr;34(2):595–598. doi: 10.1016/0003-2697(70)90146-6. [DOI] [PubMed] [Google Scholar]
  5. Krieger D. E., Erickson B. W., Merrifield R. B. Affinity purification of synthetic peptides. Proc Natl Acad Sci U S A. 1976 Sep;73(9):3160–3164. doi: 10.1073/pnas.73.9.3160. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Ling N., Esch F., Böhlen P., Brazeau P., Wehrenberg W. B., Guillemin R. Isolation, primary structure, and synthesis of human hypothalamic somatocrinin: growth hormone-releasing factor. Proc Natl Acad Sci U S A. 1984 Jul;81(14):4302–4306. doi: 10.1073/pnas.81.14.4302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Lobl T. J., Deibel M. R., Jr, Yem A. W. On-resin biotinylation of chemically synthesized proteins for one-step purification. Anal Biochem. 1988 May 1;170(2):502–511. doi: 10.1016/0003-2697(88)90665-3. [DOI] [PubMed] [Google Scholar]
  8. Miyata T., Tokunaga F., Yoneya T., Yoshikawa K., Iwanaga S., Niwa M., Takao T., Shimonishi Y. Antimicrobial peptides, isolated from horseshoe crab hemocytes, tachyplesin II, and polyphemusins I and II: chemical structures and biological activity. J Biochem. 1989 Oct;106(4):663–668. doi: 10.1093/oxfordjournals.jbchem.a122913. [DOI] [PubMed] [Google Scholar]
  9. SELA M., WHITE F. H., Jr, ANFINSEN C. B. The reductive cleavage of disulfide bonds and its application to problems of protein structure. Biochim Biophys Acta. 1959 Feb;31(2):417–426. doi: 10.1016/0006-3002(59)90016-2. [DOI] [PubMed] [Google Scholar]
  10. Suzuki K., Sasaki Y., Endo N. Tactics for simplification of purification process in the solid phase peptide synthesis. Chem Pharm Bull (Tokyo) 1976 Jan;24(1):1–9. doi: 10.1248/cpb.24.1. [DOI] [PubMed] [Google Scholar]
  11. Takahashi Y., Kato K., Hayashizaki Y., Wakabayashi T., Ohtsuka E., Matsuki S., Ikehara M., Matsubara K. Molecular cloning of the human cholecystokinin gene by use of a synthetic probe containing deoxyinosine. Proc Natl Acad Sci U S A. 1985 Apr;82(7):1931–1935. doi: 10.1073/pnas.82.7.1931. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Tesser G. I., Balvert-Geers I. C. The methylsulfonylethyloxycarbonyl group, a new and versatile amino protective function. Int J Pept Protein Res. 1975;7(4):295–305. doi: 10.1111/j.1399-3011.1975.tb02444.x. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES